atepeq/tico19 huggingface dataset:
about how long have these symptoms been going on?
Alama sabi yeyi ro alamawa kǝndondi adǝ ye dǝ fanumin dǝ?
and all chest pain should be treated this way especially with your age
kuru karuwu sǝrǝn wo so adǝyeyi ro sha cistǝyin musamman ma ro jili ngǝlinǝm adǝ lan
and along with a fever
Kuru kangewa so
and also needs to be checked your cholesterol blood pressure
Kuru man mǝradǝ kaiyisǝ bunǝmbe dǝ ye ngaltǝye mbeji
and are you having a fever now?
Kuru kǝrmaro kange fanumin wa?
and are you having any of the following symptoms with your chest pain
Kuru man alamawa kǝndondibe anyi karuwu sǝrǝn nǝm dǝga kunten fanumin wa
and are you having a runny nose?
Kuru man kǝnzanǝm sakcin wa?
and are you having this chest pain now?
Kuru man karuwu sǝrǝn adǝma kǝrmaro fanǝmin wa?
and besides do you have difficulty breathing
Kuru ngawo adǝyen yintǝnǝm dǝ kǝraw wa?
and can you tell me what other symptoms are you having along with this?
Kuru man rangnǝm wuro alamawa la kǝndondibe gade shi adǝn kunten ro gulsǝmin wa?
and does this pain move from your chest?
Kuru sǝrǝn adǝma dǝ karuwunǝm men wa kowono?
and drink lots of fluids
Kuru kumbu njiya-njiya nguwu ro yamin
and how high has your fever been
Kuru jilibi nǝm kǝrawu kange nǝm ye dǝ
and i have a cough too
Kuru nzasǝra ye dikin
and i have a little cold and a cough
kuru tantayi-a nzasǝra-a ye gana dikin
and i'm really having some bad chest pain today
Kuru wu dǝ zauro karuwu sǝrǝn fayin ku dǝ
and is this the right time for your hay fever
Kuru loktu adǝ shima wa loktu kange nǝngǝliram nǝm ye wo
and it get the chest pain
Kuru karuwu sǝrǝn na ro
and i think i have a little bit of a fever
Kuru tǝmangǝna kange gana fayin
and i want you to describe where the chest pain is
kuru wuro na dǝwo karuwu sǝrǝn dǝ fanǝmin dǝ bayannǝmiya rakǝna
and she is sorta have the same symptoms
kuru man shi dǝga alamawa kǝndondibe jili falga
and tell me what symptoms are you having now?
kuru wuro alamawa kǝndondibe jili kǝrmaro fanǝmin so dǝ gulle?
and they're having some fevers as well
Kuru sandi dǝ kange ye mbeji
and with your history of diabetes
kuru tarihinǝm kwasa shuwurbe-a
and you know it feels like my chest is like gonna crush
Kuru man karuwunyi dǝ kaltin yeyi ro fayin
and you know people cough on me all the time
Kuru man nonǝma amso ye kǝlanyi lan sambisoro sasarain
and you're having chest pain
Kuru nyi dǝ karuwunǝm sǝrǝndin
and your symptoms do not go away in five days
Kuru alamawa nǝm kǝndondibe dǝ suro kawuwa uwu ye man gozǝnyi
and you said this is a pressure in your chest
Kuru man nyi ye adǝ ma dǝ duno karuwunǝm ye wom
anyone in the family have a heart problem heart disease heart attack high cholesterol high blood pressure
Am yalla dǝ ye samma so kaziyi karuwu ye mbeji kwasa karuwu ye karuwu baktǝ tiyi lan kayasǝ nguwu kwasa karuwu baktǝ ye
any other symptoms or problems that you notice with the muscle aches?
alamawa kǝndondibe la gade aw kaziyi la fanǝma kǝndǝwu sǝrǝn ye la?
any sharp pain on your left side of your chest?
Zau la fanǝmin ma karuwunǝm shiti wofila ye dǝn mbeji wa?
are there other people sick as you at home with your same symptoms?
Am gade faton nyi ye diyeyiro dondi ma alamawa kǝndondibe ndo jili tilo wa ma mbeji wa?
are you having any difficulty breathing now
yintǝnǝm dǝ nyiya kaziyijin wa kǝrmaro
are you having any other symptoms?
alamawa kǝndondibe la gade fanǝmin ma mbeji wa?
are you having any shortness of breath?
Yintǝ kǝraw la fanǝmin wa?
are you still having the chest pain
Kwamison karuwu sǝrǝn dǝ fanǝmin wa
because this is flu season
dalilnzǝ dǝ kǝrma dǝ loktu tantayi ye nanka dǝro
besides the diabetes do you have other problems or important diseases?
kwasa shuwurbe dǝn nguron kwasa la gade kura ma nyiya zǝkjin ma mbeji wa?
but also we shouldn't be put aside for the heart cardiac origin chest pain
Amma kuru man wande andeya shitin koltǝnyi sawo kalkal sǝrǝn kwasa karuwu ye ro
but a more important problem now is this chest pain
Amma kaziyi kura dǝ kǝrmaro shima sǝrǝn karuwu ye
but if you have the cough
Amma nzasǝra nyi lan mbeji ma
but i have difficulty breathing
Amma yintǝ kǝraw wu lan mbeji
but i know lot of people cough on me
Amma nonguna am kada kǝlanyi lan kasaw sadin ro
but we need to treat every chest pain with the utmost seriousness
Amma sǝrǝn karuwu ye wo so nglaro hangal gǝnaye ciskǝyen
but you're breathing all right right now right?
Amma kǝrma dǝro nyi dǝ yintǝnǝm dǝ ngǝla la ngai gǝnyi?
'cause of this chest pain i totally forgot
Karuwu sǝrǝn adǝ ye sǝkǝ fǝdǝm njeskoko
'cause they're having a cough
Dalilnzǝ dǝ sandi dǝ sasǝrayin
does it feel like somebody squeezing your chest
Kam la ye karuwunǝm raccin yeyi ro wa fanǝmin
do still feel like shortness of breath
Kwamison yintǝ kǝraw yeyi ro wa fanǝmin
do they complain of being sick similar symptoms?
Alamawa kǝndondibe jili shima adǝro sandi dondi sa manazana wa?
do you have any blood pressure problem as far as you know?
Nyiye notǝnǝm lan kaziyi kwasa buye dǝ mbeji wa?
do you have any other chronic like high blood pressure or anything like that?
Nyi lan kwasa la kǝrawu alama kwasa bu karuwu ye so mbeji wa?
do you have any other diseases chronic medical problems like diabetes?
Nyi lan kwasawa la gade kǝraw so alama kwasa shuwurbe so mbeji wa?
do you have any shortness of breath with that chest pain?
Karuwu sǝrǝn nǝm dǝn yintǝ kǝraw ye mbeji wa?
do you have high blood pressure?
Nyi lan kwasawa bu karuwu ye mbeji wa?
do you have some shortness of breath goes with that?
nyi lan yintǝ kǝraw rokko adǝlan mbeji wa?
do you know what symptoms she was having?
nyi ye alamawa kǝndondibe shi lan mbeji ma dǝ nonǝma wa?
do your relatives have the same symptoms
Durranǝm min alamawa kǝndondibe jili adǝ mbeji wa?
do you see the image?
Foto dǝ rumin wa?
drink plenty of fluids today
kumbu njiya-njiya nguwu ro yayi ku dǝ
have a dry cough a cold and runny nose vomiting diarrhea
nzasǝra ngamdu la tantayi la-a klanza saktǝ fita yartǝ
however i take tests for the diabetes
Son yayi shùwurnyi ye ngalzana
however she has symptoms quite similar to mine
son yayi shi dǝ alamawanzǝ kǝndondibe dǝ jili kakke dǝga so kalkal
how high is your fever?
abi yeyi nǝm kǝrawu kankenǝm ye dǝ?
how' s your blood pressure?
jilibi yeyi letǝ bunǝm ye dǝ?
i don't think i have high blood pressure
tǝmagǝnyi letǝ bunyi ye dǝ zauro naa kozuna ro
i feel a pain in the chest here in the front part of the chest
Kanzuwunyi dǝn na adǝ lan zau fangin fuwu men
if you continue to have high fevers
sa kange kǝraw fanǝmin ro waljiya
if you have a fever of a hundred and two or higher
sa kange nǝm dǝ nangam miyan indin aw samin ro waljiya
if you think that your symptoms or problems warrant a better look
sa alamawa nǝm kǝndondibe dǝ aw kaziyi nǝm dǝ ngǝla cista mǝradǝzǝna ro fanǝmiya
i got a fever yesterday
biska kange fangǝna
i got a slight fever too
wu ye kange gana la fangǝna
i had a fever yesterday
biska kange ye wua sǝtana
i had a short sharp pain in my chest
karuwunyin zau miu gana fangǝna
i have a sharp pain here in the chest
karuwunyin na adǝ lan zau miu fangǝna
i have hay fever though too
amma son yayi kange nǝngǝliram ye wu lan mbeji
i have made on the body around the chest area?
wu dǝ tiinyi dǝn sak karuwu ye dǝn dikǝna?
i have some difficulty breathing too
wu dǝ yintǝ kǝraw ye fayin
i'll send you an image
nyiro foto la zuwayin
i'm having some chest pain today
wu ku dǝ karuwu sǝrǝn fayin
i'm just having some headaches and some fever today
wu dǝ biya kǝla sǝrǝn-a kange-a fayin
in my opinion it is flu
kuru nyi la dǝn adǝ tantayi
in my opinion this is a little flu
kuru nyi la dǝn adǝ tantayi kambai
i see it going from the center of your chest going up to your neck
wu sha rukin dawu karuwunǝm ye lan cizǝna dawunǝm ro letǝ sǝdin
is it like some heavy heavy person sitting on your chest?
Kam kǝraw karuwunǝmin nabsǝna yeyi wa?
it all started with the headaches and with the fever about the same time
samma so kǝla sǝrǝn dǝga kange dǝga loktu falyin badiwono
it hurts in the chest
karuwu men zaujin
it hurts in the middle of my chest
dawu karuwunyi ye men zaujin
it is a pressure like chest pain
shi dǝ biya rattǝ la karuwu sǝrǝn ye dǝyeyi
it is in my chest
suro karuwunyi ye dǝn
it is in the center of my chest
shi dǝ dawu karuwunyi ye dǝn
it is in the center of the chest
shi dǝ dawu karuwu dǝ ye dǝn
it is occurring right in the middle of my chest
shi kalkal dawu karuwunyi ye dǝn wajin
it is right in the center of my chest
shi dǝ kalkal dawu karuwunyi ye dǝn
it sounds like you just may have the garden variety cold or a flu
alamanzǝ dǝ biya wanayi tantayi nowata ma dǝ ma nyiya sǝta
i've got pain in my chest
Karuwunyin zau fayin
i've very concerned of this chest pain
wu dǝ zauro karuwu sǝrǝn adero zǝktǝkǝna
i want you to tell me in describing this chest pain
wu dǝ nyi ye wuro futu karuwu sǝrǝn ye dǝ gullimiya rakǝna
i will send you an image
nyiro foto la zuwayin
i will send you an image on your screen
nyiro foto la kǝla fuska talfonǝm ye ro zuwakin
like high blood pressure or diabetes
alama kwasa bu karuwu ye aw kwasa shuwurbe yeyi
like right in the center of the chest
alama kalkal dawu karuwu ye yeyi
most of the time it is this type of chest pain
nguwu so ro shi dǝ karuwu sǝrǝn jili adǝma
my sister has similar symptoms
Yanyi gana ferobe jili alamawa kǝndondibe jili adǝ ma shi lan
now for the fever you can take a tachipirina sweet
kǝrma dǝ kange dǝ ro rangnǝm kurun shi ro farasitamol sayin dǝ yamin
now i send you an image
kǝrma nyiro foto zuwakin
now mary how many days have you had the symptoms
mary kawu ndawu yeyi ro alamawa kǝndondibe dǝ fangam
now you said you have a chest pain
Kǝrma nyi ye karuwu sǝrǝn fanǝma wom
occasionally i have some chest pain
loktu laan karuwu sǝrǝn fayin
okay are you having any other symptoms along with this other than just the pain
ngǝla alamawa la gade rokko adǝga yen fanǝmin wa sǝrǝn sawun ba ro
or if you have high blood pressure
aw sa letǝ bu nǝm ye naa kozuna ro zuwaya
or somebody sitting on your chest?
aw karuwu kǝrautǝ?
pretty much the same with the fever and the cough headache and muscle pains
Zaumaro kange-a kǝla sǝrǝn kasau ye-a kǝndǝwu sǝrǝn-a tilo
right in the middle of my chest
kalkal dawu karuwunyi ye dǝn
show me on this image where you feel the pain
wuro foto adǝ lan na sǝrǝn fanǝmin dǝ fǝlene
since you have a fever
kange fanǝmin dǝga
so do you think that some of these symptoms could be related to being pregnant?
kurunǝm lan alamawa kǝndondibe anyi nǝm dega (suro) kǝllata wa?
so your chest pain started this morning
karuwu sǝrǝn nǝm dǝ ku suwa badiwono
so your children are having some of the same symptoms?
Daji suliya nǝm ye alamawa kǝndondibe la adǝ sandi lan mbeji wa?
tell me about your chest pain
wuro hawar karuwu sǝrǝn nǝm ye dǝ ye
the fever increases at night
kange dǝ lǝmjiya tǝrain
the fever i've had for the last two days
kange dǝwo kawu ndi kozuna adǝ lan fangǝna dǝ
the fever started to increase last night
kange dǝ biska bǝne tǝra badiwono
the fever started two days ago
kange dǝ kawu ndi kozuna de lan badiwono
the muscle pains with the hay fever
kǝndǝwu sǝrǝn dǝ-a kange nǝngǝliram dǝ-a dǝ
this is doctor porter in the emergency room triage center
adǝ shima liyita porter dǝwo njim kǝndondi kulastaye duwasashi ye dǝ
well can you tell me a little bit more about your chest pain?
ngǝla dai wuro rangnǝm bayan gade kǝla karuwu sǝrǝn nǝm ye dǝn yiramin wa?
well from my point of view it is a little flu
wu dǝga kurunyi dǝn biya tantayi gana la
well i feel a pain in the front of my body here in my chest
sǝrǝn fuwu men fayin karuwunyi men
well i've been having a strong pain in my chest
Karuwunyin zau fit fayin
well madam from listening to your symptoms it sounds like you've got one of the flu viruses
ngla ya kamu alamawa kǝndondibe nǝm dǝ kǝrǝngǝna lan fǝlezǝna alama nyi dǝ kuliya kwasabe tantayi ye dǝ ye falnzǝ nyiya sǝtana
well when i have that pain in my chest
ngǝla sa karuwunyi lan sǝrǝn todu fangiya
what kinda pain do you have in your chest?
sǝrǝn jilibi karuwunǝmin fanǝmin?
when this chest pain started?
sayi karuwu sǝrǝn adǝ badiwono?
where do you have the pain in the chest?
kalkal ndaran sǝrǝn dǝ fanǝmin karuwunǝm dǝn?
where you feel this chest pain eel this chest t
kalkal ndason karuwu sǝrǝn dǝ fanǝmin
you are probably having chest pain
nyi dǝ waneyi karuwu sǝrǝn fanǝmin
you feel like tightness on your chest
karuwunǝm dǝ zabsǝ sǝtana fanǝmin
you know i got diabetes and stuff
nonǝma wu dǝ kwasa shuwur ye-a awo gade so-a mbeji wu lan
you said you're having this chest pain
nyi ye karuwu sǝrǝn adǝ fanǝmin gulluma
Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
Nawudu ro futu kuli kwasabe koronabairos (COVID-19) dǝ European Union/European Economic Area-a United Kingdom-a, lan tǝrain dǝ tǝn 1 January sǝta 15 March 2020 ro isǝna dǝ
The cumulative incidence of coronavirus disease (COVID-19) cases is showing similar trends in European Union/European Economic Area countries and the United Kingdom confirming that, while at a different stage depending on the country, the COVID-19 pandemic is progressing rapidly in all countries.
Futu kuli kwasabe coronvirus (COVID-19) dǝ waatǝ nzǝ dǝ jili tilo fǝlejin European Union/lardǝwa European ye kasuwunzǝ sǝdin-a United Kingdom-a dǝ ye tawatsǝna kǝla, nangam wo son lǝatar lardǝ dǝ ye ro, kwasa COVID-19 ye dǝ naudu ro tǝrain lardǝwi yo son.
Based on the experience from Italy, countries, hospitals and intensive care units should increase their preparedness for a surge of patients with COVID-19 who will require healthcare, and in particular intensive care.
Futu Italy, lardǝwa, litariwa-a naa kam zauro dondi rotǝye son turuna dǝyeyi dawari nza sasara kǝla am kwasa COVID-19 ye zamzǝna dǝ nguwujin yen sandi dǝwo ne nǝlefa ro cistuwu tanas ma ro cistuwu kam zauro dondi ye mǝradzain yen.
On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China.
Yim 31 December 2019 lan, jami la kwasa nimoniya ye zamzǝna ma dǝwo futu gotin ma dǝ kǝlanzǝ notǝnyi ma ye hawar tuwondǝna suro bǝla Wuhan ye, sidi Hubei ye lardǝ China ye dǝ lan.
On 9 January 2020, the China Center for Disease Control and Prevention reported the causative agent as being a novel coronavirus now referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Yim 9 January 2020 lan, cidaram kwasa kaltǝye lardǝ China ye dǝ ye hawar awo kwasa dǝga suwudin ye cina kǝla shima kwasa bǝlin dǝwo koronabairos lan buwotin ma dǝ dǝ gullono kuru sha kwasa yintǝ dabtǝgǝ ye sha koronabairos 2 (SARS-COV-2) lan notǝna dǝ wono.
Since, the illness resulting from SARS-CoV-2 infection has been named coronavirus disease (COVID-19).
Tǝn loktu adǝn, kǝndondi dǝwo SARS-CoV-2 men wazuna wo so kwasa coronavirus yen buwotin (COVID-19).
Evidence to date is that ca 80% of individuals with COVID-19 have a mild disease, i.e. a respiratory tract infection with or without pneumonia, and most of these recover.
Kuwo so ro awo shadatǝna dǝ shima kashi 80% am dǝwo COVID-19 kwasa kambayi la sandi lan mbeji, i.e kwasa yintǝ ye nimoniya aw ba ma, kuru nguwunza so ngazana.
In ca 14% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care.
ca lan kashi 14% kwasa COVID-19 ye so, kwasa kǝraw ro lezǝ waljin shi dǝwo ne litarin buna mǝradǝzǝna ma kuru kashi 6% gabsǝna dǝ kwasa kǝraw ye sandiya zamjin shi dǝwo ne zauro cistuwu mǝradǝzǝna ma.
The mortality of patients hospitalised due to COVID-19 is ca 4%.
Batǝ dǝwo am COVID-19 ye litarin bozǝgǝna dǝ ye dǝ kashi ca 4%.
In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/European Economic Area (EU/EEA) country and the United Kingdom (UK) and compare them to that of Hubei Province, China.
Suro nazarǝ adǝ yen, ande ye futu watǝ COVID-19ye dǝ kulasnyen suro lardǝwa European Union/lardǝwa European Union ye kasuwu sǝdin (EU/EEA) kuru United Kingdom (UK)-a yen sha Hubei lardǝ China ye dǝga ratalnye ruyen.
We also compare the current number of COVID-19 cases in EU/EEA countries and the UK with that in Italy during 31 January–15 March 2020.
Ande ye kuru man nǝm nguwu am kwasa COVID-19 ye suro lardǝ EU/EEA-a UK-a kǝrma ye dǝga lardǝ Italy ye dǝga ratalnye ruyen suro yim 31 January -15 March 2020 suwudǝnan.
COVID-19 cases in EU/EEA countries and the UK
Kwasa COVID-19 suro lardǝwa EU/EEA-a UK-a yen
Subsequent to China, COVID-19 underwent further geographical spread and the dynamic of the COVID-19 pandemic in the rest of the world currently follows that of this country.
Ngawo China yen, kwasa COVID-19 ye dǝ tartǝyina kara lardǝwa dinaben kuru futu COVID-19 ye dǝ dina gabsǝna dǝn lejin dǝ futu lardǝ tudu yeyi ro lejin.
On 11 March 2020, the Director General of the World Health Organization (WHO) declared COVID-19 a pandemic.
Yim 11 March 2020 yen, Cidama kura karabka Nǝlefa ye Dinaye ma dǝ ye shi kwasa COVID-19 dǝ kwasa dina samma so ye ro wurmawono.
In the 5 March issue of Eurosurveillance 2020, Spiteri et al. reported on the first European confirmed COVID-19 cases according to the WHO case definition.
Yim 5 March lan lamar Eurosurveilance 2020, Spiteri etal. hawar kǝn hawal me COVID-19 ye cina futu WHO ye bayanzǝna ye dǝ yeyi.
In the EU/EEA, the first three confirmed cases were reported by France on 24 January 2020 in persons returning from Wuhan, Hubei Province, China.
Suro EU/EEA yen, am kwasa dǝ zamzǝna tawatkata sandi yakkǝ dǝ lardǝ France ye mauzǝ yim 24 January 2020 lan suro am dǝwo Wuhan, sidi Hubei ye lardǝ China yen isana so dǝ yen.
As at 15 March 2020, COVID-19 cases had been detected in all 30 EU/EEA countries and the United Kingdom (UK), whereby between 31 December 2019 and that date included, 39,768 cases and 1,727 deaths had been reported, with 17,750 cases and 1,441 deaths from Italy alone.
Yim 15 March 2020 lan, am kwasa COVID-19 ye zamzǝna so dǝ suro lardǝwa 30 EU/EEA-a United Kingdom (UK)-a ye samma son tuwondǝna, kuruman kate kate 31 December 2020-a kuru kawu kuntawu ye shima dǝn kunten, am kwasa dǝ ye zamzǝna 39,768-a am 1,727 bazana-a hawar tina, kuru am kwasa dǝ zamzǝna 17,750-a am 1, 441 bazana suro Italy ye runzǝ man.
Obtaining cumulative number and cumulative incidence of COVID-19 cases
Futu adadu jumla am kwasa COVID-19 ye zamzǝna ye fando
At the European Centre for Disease Prevention and Control (ECDC), the notified COVID-19 case counts in each country worldwide, obtained from only official sources such as the countries’ Ministry of Health, national and regional health authorities and the WHO, are updated each day at 8:00 a.m.
Na dawudi kwasa ro cistuwu ye Europ ye (ECDC) dǝ, hawar am kwasa COVID-19 ye zamzǝna lardǝwi yo so ye isabtin dina samma son, fantǝram maila yen tuwondǝna men alama lardǝ dǝ ye cidaramnzǝ nǝlefa ye so yeyi, wumawa nǝlefa ro cistuwu ye lardǝ ye so, WHO, soro hawar sadin wajiya son sa 8:00 a.m.
These data were used for assessing the trends of COVID-19 in EU/EEA and the UK, and comparing them to that in Italy.
Katabwa adǝn faidatǝ letǝ COVID-19 ye dǝ suro EU/ EEA-a UK-a ye dǝ ngaltin kuru sha Italy ye dǝga rataltǝyin.
As a proxy of the prevalence of active COVID-19 cases, we calculated the 14-day truncated cumulative incidence of COVID-19 cases, thus taking into account the natural course of COVID-19, in each EU/EEA country and the UK, during the 1 January–15 March 2020 period.
Alama tartǝ kwasa COVID-19 ye dǝ wakiltǝ yeyin, nde ye jumla am kwasa COVID-19 dǝ ye zamzǝna ye kawu-14 ye komnyiye, adǝyeyi men futu kwasa COVID-19 ye dǝ Alayi men gotin dǝ ye ro hangal gǝnayena, suro lardǝwa. EU/EEA-a UK-a wo son, yim 1 January-15 March 2020 ro isǝna yen.
We also presented the cumulative number of notified cases of each country as at 15 March 2020 8:00 a.m. compared with that of Italy for the 31 January–15 March 2020 period.
Adǝyeyi ma ande ye jumla adadu am kwasa dǝ ye zamzǝna ye nowata ma lardǝwi so hayena yim 15 March 2020 8:00 a.m sandiya Italy dǝga rataljiye 31 January-15 March 2020 ro suwudǝnan dǝga.
Trends of COVID-19 in EU/EEA countries and the UK
Letǝram COVID-19 ye suro lardǝwa EU/EEA- UK-a dǝ ye
The trends in the 14-day truncated cumulative incidence of COVID-19 cases in EU/EEA countries and the UK generally followed that of Hubei Province (China) (Figure 1).
Letǝram COVID-19 ye kasarrata ma kawu-14 ye ma suro EU/EEA-a UK-a ye dǝ nguwu so jili Hubei (China)ye dǝ zasaa (Sura1).
For the EU/EEA and the UK overall, the cumulative incidence of COVID-19 started to increase around 21 February and then increased sharply around 28 February 2020 (Supplementary material).
EU/EEA-a UK-a samma son, jumla COVID-19 watǝ COVID-19ye ye dǝ yim 21 February ga tǝra badiwono kuru gana waltǝ kara 28 February 2020ye dǝn tǝrana (Hujjawa duno cin ma).
This was mostly driven by the rapid increase in the number of reported cases from Italy, but all other EU/EEA countries and the UK showed similar increasing trends of the cumulative incidence of COVID-19 (Supplementary material).
Adǝ nguwu so adadu dǝwo am kwasa dǝ ye zamzǝna ye lardǝ Italy ye futu nagaduro tǝrain dǝ hawaratǝna lan tuwongatǝ, amma lardǝwa gade EU/EEA-a UK-a so dǝ letǝram futu COVID-19 ye tǝrain dǝ jili tilo fǝlezǝ (Hujjawa duno cin ma).
Figure 2 shows the cumulative number of COVID-19 cases, in EU/EEA countries and the UK compared with that in Italy for the 31 January–15 March 2020 period.
Taswira 2 dǝ fǝlejin adadu jumla am COVID-19 zamzǝna suro lardǝwa EU/EEA-a UK-a ye dǝ fǝlejin, kuru futu sha Italy ye dǝga rataltǝna dǝ yim 31 January-15 March 2020 ye ma dǝ.
It highlights that, as at 15 March 8:00 a.m., 15 other EU/EEA countries and the UK had already reported a total number of cases comparable to that of Italy just 3 weeks prior or less.
Shi dǝ fǝlezǝna kǝla, yim 15 March 8:00 a.m, lan lardǝwa gade EU/EEA-a UK-a so ye hawar buroza sadǝna kǝla jumla am kwasa dǝ ye zamzǝna ye ma dǝwo Italy ye ma dǝro ratallata ma dǝ mawu ǝ kawu dǝwo ro aw shin cidaan.
Our results indicate that the number of notified cases of COVID-19 is rapidly increasing in the EU/EEA and the UK.
Kulashinde ye fǝlezǝna kǝla adadu am dǝwo kwasa dǝ ye zamzǝna ma nowata ma so dǝ nagaduro tǝrain suro EU/EEA-a kuru UK-a ye dǝn.
The observed trends in the cumulative incidence of COVID-19 suggest that the pandemic is progressing at a comparable speed in all countries.
Futu letǝram suro jumla wawa COVID-19 ye dǝro hangal gǝnatǝna dǝ ye fǝlezǝna, kwasa dinaram adǝ nagaduro tǝrain jili tilo ro lardǝwa samma son.
This is despite countries being at different stages, variations in national public health responses, and possibly different case definitions in countries and different protocols for selecting patients that must be tested for confirmation of COVID-19, including catch-up testing.
Adǝ ye lardǝwa samma hal dasana dǝ gade gade son yayi, nǝm gade nǝlefa jamaye ro cistuwu ye, kuru waneye dǝlǝu kam kwasa COVID-19 ye sǝtana ngaltǝye, kuru man dǝlǝu kam kwasa COVID-19 ye sǝtana ngaltǝye, ngaltǝ am dareye so-a kunten.
Early March 2020, doctors in the affected regions of Italy described a situation in which ca 10% of patients with COVID-19 required intensive care and media sources reported that hospitals and intensive care units in these regions had already reached their maximum capacity.
Badiyaram kuntawu March 2020 ye, litawa naa zamtǝna suro Italy ye dǝ ye bayanzǝna kǝla ca 10% dǝwo COVID-19 ye zamzǝna so dǝ zauro cistuwu mǝradǝzǝna kuru fatowa hawar ye so gulzana kǝla litariwa so-a ba zauro am ro cistuwu ye so-a ba kek sǝmbuluwuna wada.
Data on admission of COVID-19 cases in a hospital and/or an intensive care unit are currently available at EU/EEA level for only 6% and 1% cases, respectively (data not shown).
Katabwa kǝla am COVID-19 ye sǝtana so litarin kuru/aw naa am ro zauro cistuwu ye so ba EU /EEA-a yen tuwondin 6%-a 1%-a jong yin ndaso wo so (katab dǝ fǝletǝnyi).
They should, however, be collected in a systematic fashion to complement current surveillance data that focus on the number of reported cases and the number of deaths.
Kuru adǝyeyi ma, sandiya kǝla fasal yen sabtǝ, bayan sabtǝ am zamtǝna ye kǝrmaro tǝdin dǝga banatǝ ro shi dǝwo ne kǝla am zamtǝna-a am bazana-a ro hangal cina ma dǝ.
A study performed in 2010–11 showed a large variation in the availability of intensive care and intermediate care beds in Europe, ranging from 29.2 in Germany to 4.2 beds per 100,000 population in Portugal.
Nazarǝ la 2010-11 lan tǝdǝna dǝ ye zauro naa zauro am ro cistuwu dǝ-a baa am daudau ro cistuwu ye dl-a lan zauro faltǝna ro fǝlezǝna suro Europe ye dǝn, 29.2 lan tai Germanye lan diyelwa 4.2 tǝadir jama 100,000 wo son suro Portugal yen.
This means that countries may have more or less resources than Italy (12.5 intensive care and intermediate care beds per 100,000 population in 2010–11).
Adǝbe fǝlezǝna lardǝwa do waneye Italy ga razǝwu nozain aw satinmba ( diyelwa 12.5 naa zauro am ro cistuwu ye-a naa am ro cistuwu dawu dawu ye-a tǝadir jama 100,000 suro 2010-11).
Modelling scenarios related to healthcare capacity saturation, with estimates for each EU/EEA country and the UK of the prevalence of hospitalised COVID-19 cases associated with a &gt; 90% risk of exceeding intensive care bed capacity, are provided in the sixth update of the ECDC rapid risk assessment on COVID-19.
Halla la nǝm kura nǝlefa ro cistuwu ye tandǝm tulo, lardǝwa EU/EEA-a UK-a so ro tǝadirrata kǝla am COVID-19 zamzǝ litarin rotǝna dǝ ye >90% so diyelwa naa zauro am ro cistuwu ye dǝga nǝm nguwun kozain yen, bayanzǝna suro kulashi duwaye kǝla tajirwa COVID-19 ye ECDC ye dǝn.
Since cases have so far clustered in certain regions in EU/EEA countries and the UK, and hospitals and intensive care units usually serve a defined regional catchment population, information about cases and intensive care beds should preferably be made available at the Nomenclature of territorial units for statistics 2 (NUTS-2) level.
Am zamtǝna so dǝ suro lardǝwa EU/EEA-a UK-a ye dǝn nǝm nguwunza zauro na kozuna dǝga, kuru litari so-a naa zauro am ro cistuwu ye so dǝ naa kureyata musamman ro cidayin mbeji dǝga, hawar kǝla am zamtǝna so ye dǝ-a diyelwa naa zauro am cistuwuye dǝga ca mbeji ma ngǝlawo na su ndaraye so tǝkin dǝn yisawu 2 (NUTS-2) nankaro.
The experience from Italy and the current trends in other countries show that the COVID-19 pandemic is progressing rapidly in the EU/EEA and the UK.
Futu Italy lan turuna dǝyeyi kuru futu letǝram lardǝwa gade son kǝrmaro wajin dǝ ye fǝlezǝna kǝla kwasa dinaram ye COVID-19 dǝ nagaduro tǝrain suro EU/EEA-a UK-a ye dǝn.
Countries, hospitals and intensive care units should thus prepare themselves for a scenario of sustained community transmission of SARS-CoV-2 and an increase in the number of patients with COVID-19 requiring healthcare, and in particular intensive care, such as the one occurring in the affected regions of Italy.
Lardǝwa, litariwa-a naa zauro am ro cistuwu ye-a adǝ nankadǝro kǝlanza dawarza kǝla dawari ba kǝla klalan suro jama yen SARS-COV-2 tartǝyina yen kuru adadu am COVID-19 ye zamzǝna dǝ tǝrain yen sandi dǝwo ne nǝlefa ro cistuwu mǝradǝzǝna yen, kuru tanas maro zauro cistuwu, futu jili naa dǝwo zamtǝna Italy ye dǝ yeyi.
As pointed out in the recent ECDC rapid risk assessment, a rapid, proactive and comprehensive approach is essential to delay the spread of SARS-COV-2, with a shift from a containment to a mitigation approach, as the anticipated rapid increase in the number of cases may not provide decision makers and hospitals enough time to comprehend, accept and adapt their response accordingly if not implemented ahead of time.
Futu suro ECDC ye kulashi nzǝ duwa duwabe kǝla tajirwa ye karǝngǝ ye dǝn fǝlezǝna dǝ yeyi, fasal la duwa duwaye, datelaye, kuru kǝzǝbkǝ ma dǝ zauro faida SARS-COV-2 dǝ tartǝgǝ nzǝ dǝga wahartǝge ro, cistuwu lan citǝ fasal kaltǝgǝye ro gǝrta ro, futu adadu am zamtǝna ye duwa duwa ro tǝrain ro tǝmatǝna dǝ ye waneye muwonzǝ shawari kamtǝma so-a litari so-a ro loktu kǝzǝbkǝ cǝ lamar dǝga ngǝlaro asuzainmba, samoyinmba, kuru nanza so dǝga kalkalzayinmba date lan cidatǝ baditǝnyi ma.
The rapid risk assessment also lists the public health measures to mitigate the impact of the pandemic.
Kulashi duwa duwa ye kǝla tajirwa ye dǝ kuru man katabwa nǝlefa jamaye dǝye isabsǝ suwudin kaziyi kwasa dinaram ye dǝga kambaitǝgǝ ro.
There is a short window of opportunity during which countries have the possibility to further increase their control efforts to slow down the spread of SARS-CoV-2 and decrease the pressure on healthcare.
Dǝlǝu la loktu gana ye mbeji loktu shima dǝn lardǝwa so muwonzǝ kasadǝnza SARS-COV-2 tǝ tartǝ nzǝ dǝ waharzayin kuru kǝrau kǝla nǝlefa ro cistuwu ye dǝga fuluzain.
Failing this, it is likely that the healthcare systems of other EU/EEA countries will face a surge of patients that require intensive care within the coming days or weeks.
Adǝ dewo ro teriya, tǝmatà fasalla nǝlefa ro cistuwu ye lardǝwa EU/EEA-a ye dǝ am dondi dǝwo zauro cistuwu mǝradǝzǝna kada rurutayin ro suro kaw gana aw mawwa ishin dǝ yen.
The outbreak of Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has thus far killed over 3,000 people and infected over 80,000 in China and elsewhere in the world, resulting in catastrophe for humans.
Fǝlangtǝ kwasa coronavirus (COVID-19) ye dǝ, shi dǝwo ne kwasa yintǝ dabtǝgǝ ye dǝwo (SARS) Koronabairos 2 (SARS-COV-2) ye suwudǝnan dǝ, ba burozǝ kǝrmaro am 3000 kǝn samin yeyi cezǝna kuru am 80,000 zamzǝna suro lardǝ China ye-a naa gade suro dina yen-a son, sǝkǝ tajirwa kura adam gana ro suwudǝnan.
Similar to its homologous virus, SARS-CoV, which caused SARS in thousands of people in 2003, SARS-CoV-2 might also be transmitted from the bats and causes similar symptoms through a similar mechanism.
Futu kuli kwasabe shiga samǝn ma dǝ yeyi, SARS-COV, shi dǝwo ne am duwu kada ro SARS suwudǝnan dǝ suro saa 2003, shi SARS-COV-2 dǝ ye waneye batata men gotin kuru alamawa kǝndondibe jili tilowa ma fǝlejin fasal jili tilowa men.
However, COVID-19 has lower severity and mortality than SARS but is much more transmissive and affects more elderly individuals than youth and more men than women.
Son yayi, COVID-19 dǝ nǝm zau-a tajirwa-a lan SARS ye dǝyeyi sǝtǝnyi amma shi dǝ zauro tartǝyina kuru shi dǝ am ngǝlinza lezǝna ma zauro sǝtain wo zairowa yayiro kuru kongawa ma nguwu ro sǝtain wo kamuwa yayiro.
In response to the rapidly increasing number of publications on the emerging disease, this article attempts to provide a timely and comprehensive review of the swiftly developing research subject.
Futu nagaduro kitawwa kǝla futu kwasa dǝ falangjin dǝ yen lǝbtǝ tǝrain dǝ yen, ruwo adǝ ye bayanna suro loktu yen duwa duwa ro cin kǝla mauduwa kulashi ilmu yen.
We will cover the basics about the epidemiology, etiology, virology, diagnosis, treatment, prognosis, and prevention of the disease.
Ande ye suro dǝn awowa buro hawal yin notiya sandǝna so kǝrenyen kǝla nazaru ilmuye kǝla futu kwasa tartǝyin-a kaltǝyin-a ye-a, nazaru ilmuye kǝla futu garram aw fǝrtǝ kwasabe-a, nazaru ilmuye kǝla kuli kwasabe, kulashi kǝla alamawa kǝndondiben, kurun diwo, shawari liyitaye kǝnjo, kwasa dǝn yitkawo-a
Although many questions still require answers, we hope that this review helps in the understanding and eradication of the threatening disease.
Korowa kada jawaw mǝradǝzana son yayi, tǝmanyena bayan adǝ ye banazǝ kwasawa tajirwa dǝga asutin kuru kǝriwu tin.
The Spring Festival on January 25, 2020 has become an unprecedented and unforgettable memory to all Chinese who were urged to stay indoors for all the holiday and for many weeks after due to the outbreak of a novel viral disease.
Kawuske bikaye January 25 2020 be dǝ, awo dǝwo tǝmatǝnyi kuru awo dǝwo ngaltema njastinmba ye ro walzǝna am lardǝ China ye samma so ro dǝwo sandiya sakǝ faton zakta namzana so loktu batalla shima dǝyen kuru mawwa kada ro ngawo shima dǝyen sawo falangtǝ kwasa la kǝla notǝnyi yen.
The virus is highly homologous to the coronavirus (CoV) that caused an outbreak of severe acute respiratory syndrome (SARS) in 2003; thus, it was named SARS-CoV-2 by the World Health Organization (WHO) on February 11, 2020, and the associated disease was named CoV Disease-19 (COVID-19).
Kuli kwasabe dǝ zaumaro coronavirus (CoV) dǝwo kwasa yintǝ ye (SARS) 2003; dǝ suwudǝnan dǝga samǝn adǝ sǝkǝ, karabka Nǝlefa ye Dinaye (WHO) sha SARS-COV-2 lan buwono yim February 11, 2020, kuru kwasa dǝwo shi men tuwondin dǝ kwasa-19 CoV yen buwotǝ (COVID-19).
The epidemic started in Wuhan, China, and quickly spread throughout the entire country and to near 50 others all over the world.
Kwasa dinan fomjin adǝ bǝla Wuhan, China, kuru duwa duwa ro lardǝ samma so ro tarratǝgǝ kuru lardǝwa 50 yeyi ro kǝla dina yen tarratǝgǝ.
As of March 2, 2020, the virus has resulted in over 80,000 confirmed cases of COVID-19, with more than 40,000 patients discharged and over 3,000 patients who died.
Yim March 2, 2020, kuli kwasabe dǝ am 80,000 samin yeyi COVID-19 zamzǝna ro tawatkata, kuru am 40,000 samin yeyi salamtǝna kuru am 3000 samin yeyi bazana.
WHO warns that COVID-19 is “public enemy number 1” and potentially more powerful than terrorism.
WHO be sumo gǝrzǝna kǝla COVID-19 dǝ shima watǝma jamabe kǝn falmi 1" yo wono kuru man muwonzǝ gǝradewa ma dunon kojin.
According to PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), in less than two months, over 200 papers have been published on COVID-19 including its virology, epidemiology, etiology, diagnosis, and treatment since the first report on January 7, 2020 that determined the sequence of the virus isolated from multiple patients.
Futu PubMed (https://www.ncbi.nlm.nih.gov/pubmed/) tuwondǝna ye dǝyeyi, suro kǝntawu indin cidaan yin, kakkadiwa 200 samin kǝla COVID-19 yen lǝbtǝna, suro dǝn nazaru ilmuye kǝla kuli kwasaben, nazaru ilmuye kǝla futu kwasa tartǝyin-a kaltǝyin-a ye-a, nazaru ilmuye kǝla futu garram aw fǝrtǝ kwasabe, kulashi kǝla alamawa kǝndondibe ye-a kurun diwo-a, tǝn loktu hawal hawar tuwondǝna dǝn yim January 7, 2020 lan shi dǝwo ne kuli kwasabe dǝga am gade dondi so gayerzǝna.
This review attempts to summarize the research progress in the new and swiftly developing subject area.
Nazaru adǝ kulashi ilmu ye dǝga kasarjin nasha mauduwu dǝwo maudu ro wajin ma yen.
Whenever possible, we will try to compare COVID-19 with SARS and another CoV-caused disease, Middle East respiratory syndrome (MERS, an outbreak in 2012).
Sai yayi muwongono wa, ande ye COVID-19 dǝga SARS-a kuru kwasawa la-CoV ye suwudin so-a, kwasa yintǝ ye Middle East ye (MERS, an outbreak in 2012) dǝro ratallǝyen.
We will also discuss what we have learned so far regarding the prevention and prognosis of the disease as well as some remaining yet urgent questions.
Ande ye kuru man gashibtǝyen kǝla awowa dǝwo ngawon liyena yen kǝla yitkawo-a awo kwasa dǝga suwudin-a kuru adǝyeyi ma korowa la gabsǝna gade dǝwo zauro faida so-a.
CoVs have been traditionally considered nonlethal pathogens to humans, mainly causing approximately 15% of common colds 4.
CoVs dǝ ada lan kwasa dǝwo kam so cejinmba ro nowata, alama tǝadir 15% tantayi nowata 4 suwudin.
However, in this century, we have encountered highly pathogenic human CoVs twice, i.e., SARS-CoV and MERS-CoV, which caused an outbreak originally in China in 2003 and Saudi Arabia in 2012, respectively, and soon spread to many other countries with horrible morbidity and mortality.
Adǝyeyi ma, suro karno adǝ yen, kwasa CoVs ye zauro tartǝyina ma indi kalkal ro andeya zamzǝna, i.e., SARS-CoVs, shi dǝwo ne sǝkǝ falangzǝna dǝ buro hawal yin China 2003 lan kuru Saudi Arabia lan 2012 lan, tussǝnyi kuru man lardǝwa kada ro tarratǝgǝ tartǝgǝ riyata-a tajirwa-a lan.
Therefore, the current COVID-19 is the third CoV outbreak in the recorded history of humans.
Adǝ nankadǝro, COVID-19 kǝrmaye adǝ shima falangtǝ CoV ye kǝn yakkǝ me ye wo suro tarihi adam gana ye nowata lan.
As shown in Fig. ​Fig.1,1, clusters of pneumonia that had unknown origins were first reported from Wuhan on December 31, 2019 to the China National Health Commission.
Futu Fig. Fig.1,1 fǝltǝna dǝ yeyi, kwasa nimoniya ye kǝla notǝnyi ma buro hawal yin Wuhan lan falangzǝna yim December 31, 2019 China ye cidaramnzǝ nǝlefa ro cistuwu ye dǝro hawarratǝgǝna.
Seven days later the sequence of the CoV was released.
Ngawo kawu tulur yen falangtǝ CoV ye tutǝlo.
On January 15, 2020 the first fatal case from Wuhan was reported.
Yim January 15, 2020 hawar buro hawal ye Wuhan lan tuwondǝna.
Meanwhile, the epidemic rapidly spread to the neighboring cities, provinces, and countries.
Adǝyeyi ma, kwasa dǝ tiinyi ro bǝlawa mashi so, bǝrniwa so, lardǝwa so ro tarratǝgǝ.
On January 20, the infection of health-care providers was reported, suggesting that human-to-human transmission was possible.
Yim January 20, liyitawa zamtǝna ye hawar tina, fǝlezǝna kǝla kam-kam ro fǝltǝgǝ dǝ muwonjin ro.
On January 23, the city of Wuhan was locked down with all its public transportation stopped.
Yim January 23, bǝrni Wuhan ye dǝ kǝrǝb zakkatǝgǝ awonza kǝmbaye samma dawono.
On January 24 the first clinical study on the disease reported that, out of 41 patients with confirmed cases, only 21 had direct contact with the Wuhan seafood market that was considered the starting site of the infection from an unknown animal source.
Yim January 24 nazaru liyita ye buro hawal ye kǝla kwasa dǝ yen hawar sadǝna kǝla suro am dǝwo 41 kwasa dǝ zamzǝna ro tawatkata dǝn, am 21 njong kasuwu dabba ye Wuhan ye dǝro fatta shi dǝwo ne nadǝman kwasa shima dǝ badiwono ro gotǝna dǝ dabba la notǝnyi lan ro tǝmatǝna.
On January 30, WHO declared the outbreak a global health emergency.
Yim January 30, WHO ye kwasa fǝlangtǝ dǝ kaziyi nǝlefa ye dinaye duwasashi ye sǝ mauwono.
By the time of this report, the disease has already spread throughout China and near 50 other countries all over the world (Fig. ​(Fig.2).2).
Loktu rifot adǝ tin dǝn, kwasa dǝ ba China sammaso ro tartǝgǝna kuru lardǝwa 50 samin dinaye sammaso ro (Fig.(Fig.2).2).
As the situation is rapidly evolving, the final scope and severity of the outbreak remain to be determined.
Hal adǝ nagaduro tǝrain lan, nangam darelaye-a nǝmkǝraunzǝ dǝga dǝ kwamison notǝnyi.
On February 11, 2020, a multi-center study on 8,866 patients including 4,021 confirmed COVID-19 patients presented a more updated illustration of the epidemic as follows (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Yim February 11, 2020, nazaru la fella kada kǝllataye kǝla am dondi 8,866 yen suro dǝn 4,021 dǝn am tawatkata COVID-19 ye zamzǝna ma so dǝye bayan kǝzǝbkǝ kǝla kwasa dǝ yen cina futu adǝyeyi ro (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 infected people of all ages, but mainly at the age of 30-65.
SARS-CoV-2 dǝ am ngǝliwi ye so zamzǝna, amma nguwu so 30-65.
Almost half (47.7%) of the infected individuals were over 50 years old, very few were under 20, and only 14 infected individuals were under the age of 10.
Alama reta yeyi (47.7%) am zamtǝna dǝ ye yeyi saanza 50 kozǝna wo, saa 20 cidaan dǝ zauro gana, kuru am zamtǝna 14 saa 10 cidaan wo.
SARS-CoV-2 infected more men (0.31/100,000) than women (0.27/100,000).
SARS-CoV-2 dǝ kongaa ma nguwo ro zamzǝna wo (0.31/100,000) kǝla kamuwaye ro (0.27/100,000).
COVID-19 expanded in clusters mainly in and around Hubei.
COVID-19 dǝ Kashi Kashi men suro Hubei-a dǝrinǝm kǝllenzǝga dǝn tarratǝgǝ.
COVID-19 took an average of 5 (2-9) days from onset to diagnosis.
COVID-19 dǝ alama kawu 5 (2-9) ye dǝyeyi gozǝ baditǝnzǝn tai kulashi liyita ye kude dǝn.
The average incubation period was 4.8 (3.0-7.2) days.
Loktu nzǝ kalzǝ tambin dawu-dawu ye dǝ kawu 4.8 (3.0-7.2).
The average time from onset to death was 9.5 (4.8-13) days.
Loktu nzǝ dawu-dawu ye baditǝnzǝn sǝta nonzǝ ro isǝna dǝ kawu 9.5 (4.8-13).
The basic reproductive number (R0) was 3.77 (95% CI: 3.51-4.05), and the adjusted R0 was 2.23-4.82.
Adadunzǝ tambin (R0) dǝ shima 3.77 (95% Cl: 3.51-4.05), kuru R0 tatana dǝ shima 2.23-4.82.
The number of infected people increased exponentially before 23 Jan. 2020, matching the time of massive transportation before the Spring Festival in China.
Adadu am dǝwo zamtǝna dǝ ye taidaze tǝrana kawu 23 Jan. ye ro. 2020, loktu dǝwo kawuske aw kǝmbaye suro China ye dǝga kalkal zǝna.
The mortality of patients with confirmed cases was 1.44% (95% CI: 1.10-1.86%), and the adjusted mortality of all the patients was 3.06% (95% CI: 2.02-4.59%).
Kǝrmu am dǝwo kwasa dǝ zamzǝna ro tawatkata dǝ ye dǝ 1.44% (95% Cl:1.10-1.86%), kuru kǝrmu dǝwo am dondi samma so ye tatana ma dǝ 3.06% (95% Cl:2.02-4.59%).
Three major risk factors for COVID-19 were sex (male), age (≥60), and severe pneumonia.
COVID-19 ye awowanzǝ tajirwa ro asutaye Kura kura yakkǝ dǝ shima jinsu (konga), ngǝli (≥60), kuru nimoniya kǝraw-a.
CoVs are a subfamily of large and enveloped viruses containing a single strand of sense RNA.
CoVs so dǝ yalla kulliwa kwasabe kura kura ye suronzan je RNA ye fal dǝgana ma.
They can be divided into four genera, i.e., alpha, beta, gamma, and delta, of which alpha- and beta-CoVs are known to infect humans.
Muwonzǝ sandiya kashi samǝnga diyew ro yaktin, i.e., alpha, beta, gamma, delta, suro dǝn CoVs alpha-a beta-a sandima am so ga zamjin ro nowata wo.
The envelope spike (S) glycoprotein binds to its cellular receptors angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) for SARS-CoV and MERS-CoV, respectively, and then membrane fusion occurs.
Ngǝrǝwu spike (S) glycoprotein ye dǝ awo dǝwo cellular receptors angiotensin-converting enzyme 2 (ACE2) dǝ ro kǝrtǝna kuru dipeptidyl peptidase 4 (DPP4) SARS-CoV ye-a kuru MERS-CoV so ro, kǝlatilowa ro, daji kuru membrane fusion wajin.
The viral RNA genome is released into the cytoplasm; after replication of the viral genome, genomic RNA accompanied by envelope glycoproteins and nucleocapsid proteins forms virion-containing vesicles, which then fuse with the plasma membrane to release the virus.
Kuli kwasabe RNA genome dǝ suro cytoplasm ye fitǝyin; ngawo kuli kwasabe genome kawaktǝ nguwuzǝna yen, genomic RNA dǝ ngǝrǝwu glycoproteins ye sortǝna yen, kuru nucleocapsid proteins sǝtandin virion-suro dǝn vesicles la ma, daji kuru plasma membrane dǝ ro kǝrtǝyin kuli kwasabe dǝ fituwu ro.
The first genomic sequence of SARS-CoV-2 was reported on January 10, 2020.
Wawtǝ SARS-CoV-2 buro hawal ye dǝ yim January 10, 2020 lan fangatǝ.
SARS-CoV-2 was found to be a new type of beta-CoV with more than 99.98% genetic identity among 10 sequenced samples collected from the original site of the outbreak, the Huanan Seafood Market in Wuhan.
SARS-CoV-2 dǝ shima jili beta-CoV bǝlin wo ro asutǝna samǝnram 99.98% ga suro awowa kulashi ro ba buro hawal yin falangzǝna dǝn gotǝna dǝ yen, kasuwu kǝmbu suro nji ye ma Wuhan ye dǝn.
SARS-CoV-2 is genetically more similar to SARS-CoV than to MERS-CoV.
SARS-CoV-2 dǝ alau men shima SARS-CoV ga samǝn wo MERS-CoV yayi ro.
Through transmission electron microscopy, SARS-CoV-2 particles were found in ultrathin sections of human airway epithelium.
Zawal transmission electron microscopy ye men, bǝrbǝr SARS-CoV-2 ye turuna suro zawal yintǝ ye adamngana ye dǝwo sha ultrathin sections of human airway epithelium lan buwotin dǝn.
Human ACE2 was found to be a receptor for SARS-CoV-2 as well as SARS-CoV.
ACE2 adamngana ye dǝ shima SARS-CoV-2 dǝ-a SARS-CoV dǝ-a muwoma wo ro asutuna.
However, the S protein of SARS-CoV-2 binds to human ACE2 more weakly than that of SARS-CoV, which is coincident with the fact that SARS-CoV-2 causes less severe infection in patients than SARS-CoV.
Adǝyeyi ma, S protein SARS-CoV-2 ye dǝ ACE2 adamngana ye dǝ ro lawu ro kǝrrata kǝla SARS-CoV ye yayiro, adǝ ye SARS-CoV-2 dǝ kamma zamztǝ nzǝ dǝ SARS-CoV yeyi sǝtǝnyi dǝ ye dalil.
SARS-CoV-2 can also form a novel short protein encoded by orf3b and a secreted protein encoded by orf8.
SARS-CoV-2 ye kuru man raksǝ da gana la bǝlin ma sǝdin suro orf3b kuru da fiyata suro orf8 yen gǝrata.
The orf3b of SARS-CoV-2 may play a role in the viral pathogenicity and inhibit the expression of IFNβ; however, orf8 does not contain any known functional domain or motif.
orf3b SARS-CoV-2 ye dǝ kuli kwasabe dǝ ye wuratǝ nzǝ dǝ ro takal suwudin kuru IFNβ bayantǝnzǝ dabcin; adǝyeyi ma, orf8 dǝ suro nzǝn abima faida nowata ba.
On February 18, 2020, Zhou, et al., reported the cryo-EM structure of the full-length human ACE2 at 2.9 Å resolution in complex with the amino acid transporter B0AT1.
Yim February 18, 2020, Zhou, et al., ye bayanzǝna kǝla cryo-EM siffanzǝ full-length human ACE2 kǝla nur 2.9 Å yen amino acid transporter B0AT1 ratallata.
They found that the complex, which had open and closed conformations, was assembled as a dimer and the ACE2-B0AT1 complex can bind two S proteins, which provides evidence for CoV recognition and infection.
Sandi ye asuzana kǝla complex dǝ, shi katǝram-a zaktǝrm-a ma dǝ, sha dimer yeyi ro kǝllatǝ kuru ACE2-B0AT1 complex dǝ raksǝ S proteins ndi kǝljin, adǝ dalil CoV asuta-a zamtǝnzǝ-a ye fǝlejin.
B0AT1 may become a therapeutic target for drug screening to suppress SARS-CoV-2 infection.
B0AT1 dǝ waneye shima kurun kwasa CoV-2 ratkǝm fulutǝ ye ro waljin.
The origin and intermediate host
Fǝrtǝ dǝ-a gǝnatǝna nzǝ dawu dawu ye-a
It has been known that both SARS-CoV and MERS-CoV originated from bats and were transmitted to humans via civet cats and camels, respectively.
Notǝna ye dǝ yeyi SARS-CoV dǝ-a MERS-Cov dǝ-a so fǝrtǝnza batata men ciwono kuru am so ro ngam-a kalimo-a men tarratǝgǝ.
Through a phylogenetic comparison of SARS-CoV-2 with other CoVs, bats were considered the native host of SARS-CoV-2 as the new virus is 96% identical to two SARS-like CoVs from bats called bat-SL-CoVZX45 and bat-SL-CoVZX21.
Fasal nzudu rataltǝye dǝwo phylogenetic comparison of SARS-CoV-2 dǝ men rokko CoVs gade so dǝ-a, batata so dǝ sandima ngawar SARS-CoV-2 ye wo ro gotǝna dalil dǝ kuli kwasabe bǝlin dǝ 96% ro SARS-like CoVs dǝga samǝn wo batata la sha bat-SL-CoVZX45 dǝ-a kuru bat-SL-CoVZX21 dǝ-a lan buwotin dǝ lan.
However, what intermediate host helped the virus cross the species barrier to infect humans remains unknown, and the transmission route is yet to be elucidated.
Ade yeyi ma, gǝnatǝna dawu dawu yé ndaso kuli kwasabe dǝga banaze awo kam so tartǝgǝ dǝga fanjin ma dǝga farzǝ kozǝ ma ro notǝnyi, zawal zǝga tartǝgǝna dǝ ye kwamison asutǝnyi.
Ji, et al., proposed snakes as a carrier of the virus from bats to humans which involved homologous recombination within the S protein.
Ji, et al., ye kurunzǝ dǝn kadi shima kuli kwasabe dǝga batata lan gozǝ kam so ro tarjiwo shi dǝwo ne S protein na jili tilo ro kǝltana.
According to a study, researchers in Guangzhou, China, suggested that pangolins - long-snouted, ant-eating mammals often used in traditional Chinese medicine - are the potential intermediate host of SARS-CoV-2 based on 99% genetic homology in a CoV discovered in pangolins and SARS-CoV-2.
Nazaru ilmuye lan, kulashiwu so Guangzhou, China lan, dabba la pangolins - kuruwu-sungullata, cidacida-kǝmbuma nguwu so ro sha kurun kǝska ye China yen faidatain ma- sandima gǝnatǝna SARS-CoV-2 dawu dawu ye ro waljin wada futu 99% ro CoV dǝwo pangolins-a SARS-CoV-2 lan tuwondǝna dǝga samǝn dǝ.
However, 1% difference spread all over two genomes is still a big difference; thus, conclusive results for concrete evidence are awaited (Fig. ​(Fig.33).
Adǝyeyi ma, tartǝgǝ 1% dǝwo tǝraiya yayi zauro ma ro kura, adǝ ye sǝkǝ, dalila kǝzǝbkǝ dunowa dǝ gǝretin (Fig. Fig.33).
The physicochemical properties of SARS-CoV-2 are largely not yet known.
Futu SARS-CoV-2 dǝ fafaltin so dǝ nguwu so kwamison notǝnyi.
SARS-CoV and MERS-CoV can survive in vitro for 48 hours in a dry environment and up to 5 days under 20 °C and 40%-50% humidity.
SARS-CoV dǝ-a MERS-CoV dǝ-a raksa suro kalwa yen awa 48 ro kǝnǝngatain ma ngamdu lan kuru kawu 5 ro kawdo 20 °C cidaan lan na kulongunzǝ 40%-50%.
SARS-CoV-2 may possess similar properties.
SARS-CoV-2 dǝ waneye siffa jili tilo wa ro waljin.
It has been reported that SARS-CoV-2 is sensitive to ultraviolet rays and heat at 56 °C for 30 minutes; ether, 75% ethanol, chlorine-containing disinfectant, peracetic acid, chloroform, and other fatty solvents, but not chlorhexidine, can effectively inactivate the virus.
Rifot tina kǝla SARS-CoV-2 shi dǝ nur shiro ultraviolet sayin dǝga wazǝna kuru kawudo 50 °C minti 30 ro ; ndin fal, 75% ethanol, chlorine-kurun kuli yazo ye-a kǝllatǝ ma, peracetic acid, chloroform, kuru awowa sha fatty solvents lan buwotin dǝ-a, amma chlorhexidine gǝnyi ma, raksǝ ngǝlaro kuli kwasabe dǝga cejin.
The entire human population generally lacks immunity to SARS-CoV-2 and hence is susceptible to the novel virus.
Adamngana so samma so tiyinza dǝ raksǝ SARS-CoV-2 dǝga kǝriwjinmba adǝ nankaro tiinyi kuli kwasabe bǝlin dǝ ye sha sǝtain.